Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Anzemet (dolasetron) Injection, Aventis NDA 20-624/S09 7/18/03 7/28/03 | Anzemet (dolasetron) Injection, Aventis NDA 20-624/S08 3/22/02 3/29/02 | Anzemet (Dolasetron Mesylate) Injection, Aventis NDA 20-624/S03 | Anzemet (dolasetron mesylate) Tablets, Aventis Pharma, Labeling Revision | Anzemet (dolasetron mesylate) Injection, Aventis Pharma, Labeling Revision | Anzemet (dolasetron mesylate) Tablets, Sanofi-Aventis, Labeling Revision | Anzemet (dolasetron mesylate) Injection, Sanofi-Aventis, Labeling Revision | Anzemet (dolasetron mesylate) Tablets, Sanofi-Aventis, Labeling Revision | Anzemet (dolasetron mesylate) Injection, Sanofi-Aventis, Labeling Revision | Anzemet (dolasetron mesylate) Injection, Sanofi-Aventis U.S. LLC, Labeling Revision | Anzemet (dolasetron mesylate) Tablets, Sanofi-Aventis U.S. LLC, Labeling Revision | Anzemet (dolasetron mesylate) Tablets, Sanofi-Aventis U.S. LLC, Labeling Revision | Anzemet (dolasetron mesylate) Injection, Sanofi-Aventis U.S. LLC, Labeling Revision View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com